Matches in Wikidata for { <http://www.wikidata.org/entity/Q91315859> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q91315859 description "article scientifique publié en 2018" @default.
- Q91315859 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91315859 description "scientific article published on 06 September 2018" @default.
- Q91315859 description "wetenschappelijk artikel" @default.
- Q91315859 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91315859 name "There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive" @default.
- Q91315859 name "There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive" @default.
- Q91315859 type Item @default.
- Q91315859 label "There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive" @default.
- Q91315859 label "There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive" @default.
- Q91315859 prefLabel "There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive" @default.
- Q91315859 prefLabel "There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive" @default.
- Q91315859 P1433 Q91315859-874CCBFC-A5CD-4458-8474-1E344B700B2B @default.
- Q91315859 P1476 Q91315859-C310A4DD-EB25-42A2-BC2E-FD49204C33A3 @default.
- Q91315859 P2093 Q91315859-019E0C4F-C65F-45EF-9466-645D67C4A1D0 @default.
- Q91315859 P2093 Q91315859-6DCC87B5-2C73-4236-983B-5AED0E2651FB @default.
- Q91315859 P304 Q91315859-07524EA4-5BF3-4E7F-8853-A1012FB134CA @default.
- Q91315859 P31 Q91315859-C43F3CFC-2D12-4329-8A94-FFE775AD5C74 @default.
- Q91315859 P356 Q91315859-4F4EC22C-458F-4346-8E6C-5F27803D6B5F @default.
- Q91315859 P433 Q91315859-EA5EB91F-8233-4740-B88B-7E4144AF6F10 @default.
- Q91315859 P478 Q91315859-58D3F1B7-35A9-4B23-9C72-8C41D727B7FE @default.
- Q91315859 P577 Q91315859-2ABB796E-2057-4702-9149-52B0EC576BF3 @default.
- Q91315859 P698 Q91315859-D0EFDF1A-8B85-40A4-A67B-8946978218AE @default.
- Q91315859 P356 JCO.2018.79.3166 @default.
- Q91315859 P698 30188787 @default.
- Q91315859 P1433 Q400292 @default.
- Q91315859 P1476 "There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive" @default.
- Q91315859 P2093 "Mario A Eisenberger" @default.
- Q91315859 P2093 "Pedro Isaacsson Velho" @default.
- Q91315859 P304 "3059-3060" @default.
- Q91315859 P31 Q13442814 @default.
- Q91315859 P356 "10.1200/JCO.2018.79.3166" @default.
- Q91315859 P433 "30" @default.
- Q91315859 P478 "36" @default.
- Q91315859 P577 "2018-09-06T00:00:00Z" @default.
- Q91315859 P698 "30188787" @default.